Company · mentioned 57 times
Precision oncology company that develops blood-based cancer diagnostic and screening tests, including liquid biopsy tests.
Minus One· 24 Sept
Helmy Eltoukhy says sequencing costs have fallen from $3 billion to $1,000 to $100 to $10 to $1, and Guardant Health's tests will collect 10x, 100x and 1,000x more data per test.Invest Like the Best with Patrick O'Shaughnessy· 21 Apr
Guardant Health developed a simple blood test for colorectal cancer after learning from Exact Sciences' stool-based test.Minus One· 19 Feb
Mark Jacobstein says he thought 'president of what?' when Andrew Yang told him at Guardant Health that he was running for president, because the idea is normally to run from the establishment as a congressman or senator.